Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Dokl Biochem Biophys ; 516(1): 98-106, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38539010

RESUMEN

Analysis of the mechanisms underlying the occurrence and progression of cancer represents a key objective in contemporary clinical bioinformatics and molecular biology. Utilizing omics data, particularly transcriptomes, enables a detailed characterization of expression patterns and post-transcriptional regulation across various RNA types relative to the entire transcriptome. Here, we assembled a dataset comprising transcriptomic data from approximately 16 000 patients encompassing over 160 types of cancer. We employed state-of-the-art gradient boosting algorithms to discern intricate correlations in the expression levels of four clinically significant microRNAs, specifically, hsa-mir-21, hsa-let-7a-1, hsa-let-7b, and hsa-let-7i, with the expression levels of the remaining 60 660 unique RNAs. Our analysis revealed a dependence of the expression levels of the studied microRNAs on the concentrations of several small nucleolar RNAs and regulatory long noncoding RNAs. Notably, the roles of these RNAs in the development of specific cancer types had been previously established through experimental evidence. Subsequent evaluation of the created database will facilitate the identification of a broader spectrum of overarching dependencies related to changes in the expression levels of various RNA classes in diverse cancers. In future, it will make possible to discover unique alterations specific to certain types of malignant transformations.


Asunto(s)
Aprendizaje Automático , MicroARNs , Neoplasias , Transcriptoma , MicroARNs/genética , Humanos , Neoplasias/genética , Neoplasias/metabolismo , Regulación Neoplásica de la Expresión Génica , Perfilación de la Expresión Génica
2.
Inflamm Res ; 71(5-6): 627-639, 2022 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-35434745

RESUMEN

OBJECTIVE AND DESIGN: The existing biological models of diffuse alveolar damage (DAD) in mice have many shortcomings. To offset these shortcomings, we have proposed a simple, nonsurgical, and reproducible method of unilateral total damage of the left lung in ICR mice. This model is based on the intrabronchial administration of a mixture of bacterial lipopolysaccharide (LPS) from the cell wall of S. enterica and α-galactosylceramide (inducing substances) to the left lung. METHODS: Using computer tomography of the lungs with endobronchial administration of contrast material, we have been able to perform an operative intravital verification of the targeted delivery of the inducer. The model presented is characterized by more serious and homogeneous damage of the affected lung compared to the existing models of focal pneumonia; at the same time, our model is characterized by longer animal survival since the right lung remains intact. RESULTS: The model is also characterized by diffuse alveolar damage of the left lung, animal survival of 100%, abrupt increases in plasma levels of TNFa, INFg, and IL-6, and significant myocardial overload in the right heart. It can be used to assess the efficacy of innovative drugs for the treatment of DAD and ARDS as the clinical manifestations that are developed in patients infected with SARS-CoV-2. Morphological patterns of lungs in the noninfectious ("sterile") model of DAD induced by LPS simultaneously with α-galactosylceramide (presented here) and in the infectious model of DAD induced by SARS-CoV-2 have been compared. CONCLUSION: The DAD model we have proposed can be widely used for studying the efficacy of candidate molecules for the treatment of infectious respiratory diseases, such as viral pneumonias of different etiology, including SARS-CoV-2.


Asunto(s)
COVID-19 , Neumonía Viral , Animales , Modelos Animales de Enfermedad , Humanos , Lipopolisacáridos , Pulmón , Ratones , Ratones Endogámicos ICR , SARS-CoV-2
3.
Dokl Biochem Biophys ; 493(1): 193-197, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32894463

RESUMEN

The cellular response to DNA damage protects the essential information stored in the genome. This mechanism is crucial in terms of the cancer prevention and aging progression. The DNA damage response (DDR) consists of a complex network controlling the cell cycle and multiple mechanisms of the DNA repair. The DDR disruption is a cornerstone feature of the tumor cells, which allows them to enhance beneficial mutations that prevent successful disease treatment. The important checkpoints of the DDR are currently poorly understood due to the complexity and diversity of the DNA repair machinery. Histone ubiquitination is intensively involved in the repair of the double-stranded DNA breaks. This post-translational modification is known to be a key factor in the recruitment of the repair factors to the DNA damage sites. Here, the crucial role of the ubiquitin lysine residue K27 in the process of histone H2A monoubiquitination mediated by the ubiquitin ligase RNF168 has been showed. The presented data suggest forced and intensive diffusion of ubiquitin from the cytoplasm to the nucleus, which is characterized by the dynamic equilibrium less than 10 min. The comparison of the turnover rate of the wild-type ubiquitin and its variant with a single functional lysine residue K27 suggests an important role of the ubiquitin deposition as a covalent conjugate with histone H2A in terms of the stability of the entire ubiquitinome.


Asunto(s)
Daño del ADN , Reparación del ADN , Histonas/genética , Histonas/metabolismo , Ubiquitina/metabolismo , Células Cultivadas , Cromatina/genética , Cromatina/metabolismo , Histonas/química , Humanos , Procesamiento Proteico-Postraduccional , Transducción de Señal , Ubiquitina-Proteína Ligasas/genética , Ubiquitina-Proteína Ligasas/metabolismo , Ubiquitinación
4.
Biochemistry (Mosc) ; 84(Suppl 1): S159-S192, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31213201

RESUMEN

In the middle of the 20th century, it was postulated that degradation of intracellular proteins is a stochastic process. More than fifty years of intense studies have finally proven that protein degradation is a very complex and tightly regulated in time and space process that plays an incredibly important role in the vast majority of metabolic pathways. Degradation of more than a half of intracellular proteins is controlled by a hierarchically aligned and evolutionarily perfect system consisting of many components, the main ones being ubiquitin ligases and proteasomes, together referred to as the ubiquitin-proteasome system (UPS). The UPS includes more than 1000 individual components, and most of them are critical for the cell functioning and survival. In addition to the well-known signaling functions of ubiquitination, such as modification of substrates for proteasomal degradation and DNA repair, polyubiquitin (polyUb) chains are involved in other important cellular processes, e.g., cell cycle regulation, immunity, protein degradation in mitochondria, and even mRNA stability. This incredible variety of ubiquitination functions is related to the ubiquitin ability to form branching chains through the ε-amino group of any of seven lysine residues in its sequence. Deubiquitination is accomplished by proteins of the deubiquitinating enzyme family. The second main component of the UPS is proteasome, a multisubunit proteinase complex that, in addition to the degradation of functionally exhausted and damaged proteins, regulates many important cellular processes through controlled degradation of substrates, for example, transcription factors and cyclins. In addition to the ubiquitin-dependent-mediated degradation, there is also ubiquitin-independent degradation, when the proteolytic signal is either an intrinsic protein sequence or shuttle molecule. Protein hydrolysis is a critically important cellular function; therefore, any abnormalities in this process lead to systemic impairments further transforming into serious diseases, such as diabetes, malignant transformation, and neurodegenerative disorders (multiple sclerosis, Alzheimer's disease, Parkinson's disease, Creutzfeldt-Jakob disease and Huntington's disease). In this review, we discuss the mechanisms that orchestrate all components of the UPS, as well as the plurality of the fine-tuning pathways of proteasomal degradation.


Asunto(s)
Enfermedades Neurodegenerativas/metabolismo , Complejo de la Endopetidasa Proteasomal , Proteolisis , Ubiquitinas , Humanos , Complejo de la Endopetidasa Proteasomal/química , Complejo de la Endopetidasa Proteasomal/fisiología , Transducción de Señal , Ubiquitinación , Ubiquitinas/química , Ubiquitinas/fisiología
5.
Bull Exp Biol Med ; 161(1): 69-71, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-27270938

RESUMEN

We studied the effect of ß1i-specific peptidyl aldehyde IPSI-001 on proteasome from mammalian cells. In concentrations <1 µM, this agent effectively suppressed immunoproteasome, but only slightly reduced chymotrypsin-like activity of constitutive proteasome. Intraperitoneal administration of this inhibitor to C3H/He mice in a dose of 100 mg/kg induced no significant physiological or behavioral changes, which attested to its considerable therapeutic potential in the treatment of autoimmune neurodegenerative pathologies.


Asunto(s)
Dipéptidos/farmacología , Complejo de la Endopetidasa Proteasomal/efectos de los fármacos , Animales , Conducta Animal/efectos de los fármacos , Línea Celular , Humanos , Ratones , Ratones Endogámicos C3H , Proteína Básica de Mielina/metabolismo
6.
Dokl Biochem Biophys ; 469(1): 277-80, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27599511

RESUMEN

Deimination of myelin basic protein (MBP) by peptidylarginine deiminase (PAD) prevents its binding to the proteasome and decelerates its degradation by the proteasome in mammalian cells. Potential anticancer drug tetrazole analogue of chloramidine 2, at concentrations greater than 1 µM inhibits the enzymatic activity of PAD in vitro. The observed acceleration of proteasome hydrolysis of MBP to antigenic peptides in the presence of PAD inhibitor may increase the efficiency of lesion of the central nervous system by cytotoxic lymphocytes in multiple sclerosis. We therefore suggest that clinical trials and the introduction of PAD inhibitors in clinical practice for the treatment of malignant neoplasms should be performed only after a careful analysis of their potential effect on the induction of autoimmune neurodegeneration processes.


Asunto(s)
Compuestos de Bifenilo/farmacología , Hidrolasas/antagonistas & inhibidores , Hidrolasas/metabolismo , Proteína Básica de Mielina/metabolismo , Fármacos Neuroprotectores/farmacología , Complejo de la Endopetidasa Proteasomal/metabolismo , Tetrazoles/farmacología , Animales , Bortezomib/farmacología , Bovinos , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/farmacología , Células HEK293 , Humanos , Hidrolasas/genética , Hidrólisis , Ratones Endogámicos C3H , Esclerosis Múltiple/tratamiento farmacológico , Esclerosis Múltiple/metabolismo , Músculo Esquelético/enzimología , Proteína Básica de Mielina/genética , Unión Proteica/fisiología , Desiminasas de la Arginina Proteica , Proteolisis , Conejos , Transfección
7.
Dokl Biochem Biophys ; 469(1): 264-8, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27599508

RESUMEN

In this study, we performed transcriptome profiling of oligodendrocyte culture of mice treated with the remyelinating therapeutic agent benztropine in the presence and absence of interferon gamma (IFNγ). The results of this work are important for understanding the expression profile of oligodendrocytes under conditions of systemic inflammation in the central nervous system in multiple sclerosis as well as the mechanisms of cellular response to benztropine in light of its possible use for the treatment of multiple sclerosis.


Asunto(s)
Oligodendroglía/inmunología , ARN Mensajero/inmunología , Transcriptoma/inmunología , Animales , Antiinflamatorios/farmacología , Benzotropina/farmacología , Células Cultivadas , Perfilación de la Expresión Génica , Factores Inmunológicos/farmacología , Interferón gamma/farmacología , Ratones Endogámicos C3H , Oligodendroglía/efectos de los fármacos , Complejo de la Endopetidasa Proteasomal/efectos de los fármacos , Complejo de la Endopetidasa Proteasomal/inmunología , Transcriptoma/efectos de los fármacos
8.
Acta Naturae ; 12(1): 18-32, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32477595

RESUMEN

Autophagy is a conservative and evolutionarily ancient process that enables the transfer of various cellular compounds, organelles, and potentially dangerous cellular components to the lysosome for their degradation. This process is crucial for the recycling of energy and substrates, which are required for cellular biosynthesis. Autophagy not only plays a major role in the survival of cells under stress conditions, but is also actively involved in maintaining cellular homeostasis. It has multiple effects on the immune system and cellular remodeling during organism development. The effectiveness of autophagy is ensured by a controlled interaction between two organelles - the autophagosome and the lysosome. Despite significant progress in the description of the molecular mechanisms underlying autophagic-lysosomal system (ALS) functioning, many fundamental questions remain. Namely, the specialized functions of lysosomes and the role of ALS in the pathogenesis of human diseases are still enigmatic. Understanding of the mechanisms that are triggered at all stages of autophagic- lysosomal degradation, from the initiation of autophagy to the terminal stage of substrate destruction in the lysosome, may result in new approaches that could help better uderstand ALS and, therefore, selectively control cellular proteostasis.

9.
Acta Naturae ; 11(2): 28-41, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31413877

RESUMEN

The possibility of targeted drug delivery to a specific tissue, organ, or cell has opened new promising avenues in treatment development. The technology of targeted delivery aims to create multifunctional carriers that are capable of long circulation in the patient's organism and possess low toxicity at the same time. The surface of modern synthetic carriers has high structural similarity to the cell membrane, which, when combined with additional modifications, also promotes the transfer of biological properties in order to penetrate physiological barriers effectively. Along with artificial nanocages, further efforts have recently been devoted to research into extracellular vesicles that could serve as natural drug delivery vehicles. This review provides a detailed description of targeted delivery systems that employ lipid and lipid-like nanocages, as well as extracellular vesicles with a high level of biocompatibility, highlighting genetically encoded drug delivery vehicles.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA